US PET Scanners Market Report 2025–2033: Products, Modalities, Trends

United States PET Scanners Market Forecast (2025–2033)

According to Renub Research United States PET (Positron Emission Tomography) Scanners Market is projected to expand steadily over the forecast period, rising from US$ 0.82 billion in 2024 to approximately US$ 1.07 billion by 2033, at a CAGR of 2.95% from 2025 to 2033. This growth is underpinned by increasing clinical demand for accurate diagnostic imaging, rising cases of chronic and neurological diseases, and continuous advancements in hybrid and digital PET technologies.

PET scanners have become indispensable tools in U.S. medical imaging, playing a crucial role in oncology, neurology, cardiology, and emerging areas of precision medicine. As healthcare providers continue to invest in technological upgrades and advanced diagnostic capabilities, the PET scanners market is expected to maintain its upward trajectory throughout the coming decade.

United States PET Scanners Industry Overview

The United States remains one of the most technologically advanced diagnostic imaging markets globally, with PET scanners forming a fundamental component of its healthcare infrastructure. PET imaging enables clinicians to measure metabolic activity and detect functional changes within tissues long before anatomical abnormalities become visible. This ability to identify disease at early stages makes PET scanners highly valuable for clinical decision-making, especially in oncology.

The increasing incidence of cancer, cognitive disorders, and heart disease has heightened demand for sophisticated imaging tools. PET scanners offer superior sensitivity compared to conventional imaging modalities like MRI or CT when assessing tumor metabolism, neuronal activity, and perfusion abnormalities. As a result, U.S. hospitals, cancer care centers, and research institutions continue to expand PET imaging services.

The market is also strongly influenced by technological innovation, including the integration of hybrid systems such as PET/CT and PET/MRI, the adoption of digital detector technologies, and the development of new radiotracers tailored for specific disease pathways. The rapid shift toward AI-assisted imaging, cloud-based diagnostic workflows, and quantitative imaging tools further enhances PET scanner utilization across clinical settings.

Government-backed research funding, investments from healthcare networks, and public-private partnerships are accelerating innovation in molecular imaging. These collaborations are expanding PET scan applications beyond cancer detection and paving the way for advanced uses such as monitoring neurodegenerative diseases, assessing cardiac viability, and tracking infections.

Despite this significant progress, the U.S. market continues to face challenges. High capital costs, complex regulatory pathways, staffing shortages, and reimbursement limitations can influence adoption rates—particularly in smaller hospitals. However, the overall outlook remains positive, with PET imaging becoming increasingly integral to U.S. healthcare delivery.

Request a free sample copy of the report:https://www.renub.com/request-sample-page.php?gturl=north-america-podcasting-market-p.php

Key Factors Driving the Growth of the United States PET Scanners Market

1. Rising Prevalence of Chronic and Neurological Diseases

The growing incidence of chronic illnesses—especially cancer and neurological disorders—is a major driver shaping PET scanner demand in the United States. PET imaging is widely used for early tumor detection, therapy response evaluation, and restaging, making it a cornerstone of modern oncology care.

Neurological applications are also growing rapidly. PET scans play a critical role in diagnosing and monitoring:

·       Alzheimer’s disease

·       Parkinson’s disease

·       Epilepsy

·       Dementia-related metabolic changes

·       Traumatic brain injuries

As the U.S. population ages, the demand for high-accuracy, non-invasive neuroimaging is expected to rise sharply. Research into disease-specific radiotracers is further strengthening PET’s relevance in neurological diagnostics.

2. Technological Advancements and Growing Adoption of Hybrid Imaging

Technological innovation remains the backbone of the PET scanners industry. Over the last decade, hybrid imaging systems—such as PET/CT and PET/MRI—have become standard in advanced imaging centers. These systems combine metabolic and anatomical information, offering clinicians comprehensive and precise diagnostic insights.

Cutting-edge advancements include:

·       Digital PET detectors for higher resolution and greater sensitivity

·       Time-of-Flight (TOF) technology, improving imaging clarity

·       AI-powered image reconstruction, lowering radiation doses and enhancing processing speed

·       Automated workflow tools, reducing exam time and improving patient throughput

·       Next-generation radiotracers, enabling targeted imaging of specific cells and organ systems

Hybrid imaging is also supporting the rise of precision medicine, where treatments are tailored to an individual's biological characteristics. As precision oncology and personalized neurology continue to advance, PET scanners are becoming more central to clinical evaluation and therapeutic monitoring.

3. Expanding Healthcare Infrastructure and Research Initiatives

The modernization of healthcare infrastructure, increasing funding for imaging research, and expansion of diagnostic networks are supporting market growth. Public and private healthcare providers are investing heavily in molecular imaging capabilities to meet growing demand.

Key trends include:

·       Expansion of PET imaging in academic hospitals

·       Increased participation in clinical trials requiring molecular imaging

·       Advancements in radiopharmaceutical development

·       Government initiatives supporting early detection and cancer screening

·       Growing collaboration between imaging equipment makers and research institutions

Additionally, U.S. healthcare spending continues to rise, enabling hospitals and diagnostic centers to upgrade older imaging systems with more efficient, accurate, and lower-dose PET scanners.

Challenges in the United States PET Scanners Market

1. High Installation and Maintenance Costs

PET scanners are among the most expensive medical imaging systems, posing a significant financial barrier for many facilities. Costs include:

·       Equipment purchase

·       Facility modification and radiation shielding

·       Radiopharmaceutical storage and handling

·       System calibration and maintenance

·       Hiring and training specialized nuclear medicine personnel

Smaller hospitals and rural healthcare providers often struggle to justify these expenses, limiting market penetration in less urbanized regions. While shared imaging models and equipment leasing options are emerging, affordability remains a key challenge.

2. Regulatory and Reimbursement Constraints

The U.S. regulatory environment for PET imaging is stringent. Approval processes for new scanners, radiopharmaceuticals, and imaging protocols may be lengthy and complex. Moreover, reimbursement variability across Medicare, Medicaid, and private insurers can limit investments in advanced imaging equipment.

Additional constraints include:

·       Evolving safety standards for radiation exposure

·       Data protection and imaging storage requirements

·       Limited reimbursement for newer radiotracers and emerging clinical applications

These factors can slow adoption and create operational challenges for imaging centers.

United States PET Scanners Market Overview by States

California

California stands at the forefront of PET scanner adoption due to its world-class healthcare institutions, extensive cancer treatment networks, and strong focus on medical research. High prevalence of chronic and neurological diseases drives demand across hospitals and diagnostic centers. The state’s leadership in biotechnology also supports advanced radiotracer development, while growing investments in AI-integrated imaging systems reinforce California’s role as a major PET market.

Texas

Texas represents one of the fastest-growing PET scanner markets, driven by an expanding healthcare network, rising population, and increasing chronic disease burden. Major cities such as Houston, Dallas, and Austin host advanced imaging centers equipped with hybrid PET/CT and PET/MRI systems. Rural healthcare development and tele-diagnostics are helping extend PET imaging access across underserved regions.

New York

New York’s PET scanners market thrives on strong research activity, high disease prevalence, and the presence of leading academic medical centers. The state has been an early adopter of hybrid imaging solutions and remains heavily involved in clinical trials involving PET technology. Dense urban populations and high patient volumes support consistent PET scan utilization across oncology, neurology, and cardiology.

Florida

Florida’s aging population makes it one of the most important markets for PET scanners. The state faces a high incidence of cancer, cardiovascular disease, and cognitive disorders, necessitating widespread PET imaging. Healthcare providers continue investing in advanced PET/CT systems for early detection and improved treatment planning. Florida also has an active medical research community exploring innovative radiotracers and neuroimaging techniques.

Market Segmentations

By Product Type

·       Full Ring PET Scanner

·       Partial Ring PET Scanner

By Modality

·       PET-CT

·       PET-MRI

By Application

·       Oncology

·       Cardiology

·       Neurology

·       Others

By End Use

·       Hospitals

·       Diagnostic Imaging Centers

·       Academic & Research Institutes

By State

California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio, Georgia, New Jersey, Washington, North Carolina, Massachusetts, Virginia, Michigan, Maryland, Colorado, Tennessee, Indiana, Arizona, Minnesota, Wisconsin, Missouri, Connecticut, South Carolina, Oregon, Louisiana, Alabama, Kentucky, Rest of United States

Key Companies Covered

·       Canon Medical Systems

·       GE Healthcare

·       Kindsway Biotech

·       Koninklijke Philips N.V.

·       Mediso Ltd.

·       PerkinElmer

·       Positron Corporation

·       Shimadzu Corporation

·       Siemens Healthineers

Each organization contributes to the market through innovation in hybrid imaging, radiopharmaceutical development, AI-driven diagnostics, and service expansion.